During the last two decades, we have witnessed a worldwide spreading of Robot-Assisted Laparoscopic Surgery (RALS) in urology, particularly in the oncology field. Within the urological community, RALS represents nowadays the reference standard approach for the surgical treatment of prostate and renal tumors and robot-assisted radical cystectomy is currently gaining an increasing consensus.1